Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

The "full price" here was 15 percent of GlaxoSmithKline's revenue last year. They spent 40 percent on marketing. When can this myth die?

http://www.bizjournals.com/triangle/news/2016/07/19/where-gs...



Probably about the same time as people stop equating "general and administration expenses" with "marketing". Marketing is a subset of that.


Yes, it also includes buying lunches for doctors and private jets for the executive staff. What it does not include is R&D in any shape or form. The fact is R&D isn't making drug prices high.


Oy. It also includes paying the janitors, the property taxes, and the myriad of other costs that come with running a company.

> The fact is R&D isn't making drug prices high.

Neither are their SGA expenses. The two combined are just under half GSK's revenue.

Anyway, that's irrelevant to trying to score cheap points with a false equivalence.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: